On the fly News and insights, exclusive to thefly.com

2020-08-04 10:14:46 NBIX Neurocrine $120.02 / -3.15 (-2.56%) , CLI Mack-Cali Realty $13.03 / -0.2 (-1.51%) … 10:14 08/04/20 08/04 10:14 08/04/20 10:14	Fly Intel: Top five analyst downgrades Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Neurocrine (NBIX) downgraded to Neutral from Overweight at JPMorgan with analyst Anupam Rama citing valuation. 2. Mack-Cali Realty (CLI) downgraded to Hold from Buy at Deutsche Bank. 3. Container Store (TCS) downgraded to Sell from Neutral at Goldman Sachs with analyst Kate McShane saying consensus estimates for the company are too high due to heightened competition, the "highly discretionary" nature of the category, pull-forward in demand from stay-at-home trends, and inventory out-of-stocks for in-demand categories. 4. Freeport McMoRan (FCX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Carlos De Alba citing the recent strong rally in the shares. 5. Take-Two (TTWO) downgraded to Underperform from Neutral at BofA with analyst Ryan Gee saying the upside in Q1 may already be priced into the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here. NBIX Neurocrine $120.02 / -3.15 (-2.56%) CLI Mack-Cali Realty $13.03 / -0.2 (-1.51%) TCS Container Store $3.30 / -0.19 (-5.44%) FCX Freeport-McMoRan $12.61 / -0.495 (-3.78%) TTWO Take-Two $174.15 / +6.14 (+3.65%)	04 Aug 12 Aug 26 Aug

2020-08-04 10:14:46

NBIX

Neurocrine

$120.02 / -3.15 (-2.56%)

, CLI

Mack-Cali Realty

$13.03 / -0.2 (-1.51%)

… 10:14

08/04/20

08/04

10:14

08/04/20

10:14

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Neurocrine (NBIX) downgraded to Neutral from Overweight at JPMorgan with analyst Anupam Rama citing valuation. 2. Mack-Cali Realty (CLI) downgraded to Hold from Buy at Deutsche Bank. 3. Container Store (TCS) downgraded to Sell from Neutral at Goldman Sachs with analyst Kate McShane saying consensus estimates for the company are too high due to heightened competition, the "highly discretionary" nature of the category, pull-forward in demand from stay-at-home trends, and inventory out-of-stocks for in-demand categories. 4. Freeport McMoRan (FCX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Carlos De Alba citing the recent strong rally in the shares. 5. Take-Two (TTWO) downgraded to Underperform from Neutral at BofA with analyst Ryan Gee saying the upside in Q1 may already be priced into the shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

NBIX

Neurocrine